ARTELO BIOSCIENCES, INC. Increase (Decrease) in Due to Related Parties
ARTELO BIOSCIENCES, INC. (ARTL) reported Increase (Decrease) in Due to Related Parties of $11.00 thousand for the 3-month period ending 2021-11-30, per its 10-Q filed 2022-01-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedParties · last filed 2022-01-12
- ARTELO BIOSCIENCES, INC. increase (decrease) in due to related parties for the quarter ending 2021-11-30 was $11.00K, a 21.43% decline year-over-year.
- ARTELO BIOSCIENCES, INC. increase (decrease) in due to related parties for the quarter ending 2020-11-30 was $14.00K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in due to related parties for the quarter ending 2017-05-31 was $4.20K.
- ARTELO BIOSCIENCES, INC. increase (decrease) in due to related parties for the quarter ending 2017-02-28 was $0.00.
| Period end | Increase (Decrease) in Due to Related Parties 3 month | Increase (Decrease) in Due to Related Parties 6 month | Increase (Decrease) in Due to Related Parties 9 month |
|---|---|---|---|
| 2021-11-30 | $11.00K 10-Q · filed 2022-01-12 | ||
| 2020-11-30 | $14.00K 10-Q · filed 2022-01-12 | ||
| 2017-05-31 | $4.20K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2018-07-13 | $4.20K derived: sum of 2 quarters · filed 2018-07-13 | $16.61K 10-Q · filed 2018-07-13 |
| 2017-02-28 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2018-05-14 | $12.41K 10-Q/A · filed 2018-05-14 | |
| 2016-11-30 | $12.41K 10-Q · filed 2017-01-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B |